JUL 30, 2018 03:00 PM PDT

Challenges Coming to a Cancer Diagnosis in the UK

England’s National Health Service (NHS) published their 2017 Cancer Patient Experience Survey earlier this year; many patients indicated being well served and felt positively about their experience but there were some areas of concern as well.

This Cancer Patient Experience survey has been conducted annually for the past 7 years, starting back in 2010.  The goal was to monitor national progress on cancer care from the patient perspective.  There were determined to be over 110,000 cancer patients available for the survey and over 69,000 responded (63% response rate). 

After data was collected, it was compared and analyzed from multiple perspectives; it was in this comparison that one area has drawn some attention.  One question, number 1 in fact, asked patients how often they saw their general practitioner about the health problem caused by cancer?  The purpose of this question was to get at how long did it take for a patient’s complaint, which was ultimately tied to a cancer diagnosis, to be referred to a specialist or hospital?  The root of this issue being the challenge that General Practitioners (GP) face in filtering a lot of information across the whole physiological spectrum of humans to pinpoint symptoms with a particular diagnosis.  The data on this question was aligned by type of cancer category (there were 13 total categories based on the location of the primary tumor/cancer).

Turns out that of the 11,000 patients with a hematological cancer (cancer of the blood), nearly 11 percent had to see their family doctor 5 or more times before the symptoms matched up with the diagnosis.  When those that had to see their family doctor 3 or 4 more times is combined with those that made more than 5 visits, the percentage of patients affected jumps to over 27%.  That is more than a quarter of patients.  This was much higher than for other categories of cancer.  The next closest category of cancer to this percentage was bone and soft tissue sarcomas at 26%, and 23% for lung cancers.  Overall, the total percentage for all cancer diagnoses that took 3 or more visits to a GP was 17%. 

Healthcare advocates in the UK might consider further education or updates for GPs on symptoms of these particular cancers as an intervention aimed at bettering these numbers for the future; while definitely a good idea for any provider, hopefully those looking at this will also recognize the challenge that GPs face in making a diagnosis or referral for cancers like these.  First, a GP is not a specialist by trade but has to be the “handyman” for healthcare.  The GP knowledge base must be both broad AND detailed in all areas of the human body.  It is only getting more challenging with healthcare advances and complex diseases.  Second, the symptoms associated with hematological cancers and sarcomas are often very vague and indicative of many different diseases or conditions.  If the cancer is not advanced enough to have caused severe symptoms, often it is a routine exam or random exam for an extensive time period of feeling tired, where hematological cancers are found.  Symptoms are not necessarily acute in many patients; triage, ruling out of other conditions, and consideration of cost are all factored into rushing to high complexity (read high cost) testing and potentially unnecessary concern for a patient and their family.  It is a balancing act that most providers face daily.

The data shows opportunities for improvement in GP’s diagnostic skill related to certain types of cancers as perceived by this patient experience survey and that is very important for those patients whose diagnosis took longer to get to. 

Source: National Cancer Patient Experience Survey,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
JUN 25, 2018
Cancer
JUN 25, 2018
B-cell Lymphoma Develops After MPN JAK1/2 Therapy
Patients with myeloproliferative neoplasms treated with JAK1/2 inhibitor therapy are at increased risk of developing aggressive B-cell lymphoma due to pre-existing B-cell clone specifically a...
JUN 27, 2018
Cell & Molecular Biology
JUN 27, 2018
Finding a new way to Stop the Growth of Cancer
Scientists discovered something new about the behavior of an organelle called ribosomes in cancer cells....
AUG 15, 2018
Cancer
AUG 15, 2018
Cancer Control Headway in The Last 20 Years
Learning from history and what changes have been made will continue to help drive cancer controls for the future....
AUG 21, 2018
Health & Medicine
AUG 21, 2018
First, They Came for the Straws...Now the Soda?
Bans on plastic straws and utensils are all over the news recently. While taking care of the planet is crucial, some critics say that banning plastic straw...
SEP 05, 2018
Videos
SEP 05, 2018
Why Glioblastoma Is So Deadly
Senator John McCain passed away recently after battling brain cancer. Most forms of brain cancer are aggressive and difficult to treat because medications...
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
Loading Comments...